New Approaches in Hypertension Management: a Review of Current and Developing Technologies and Their Potential Impact on Hypertension Care

Jamie Kitt, Rachael Fox, Katherine L Tucker, Richard J McManus, Jamie Kitt, Rachael Fox, Katherine L Tucker, Richard J McManus

Abstract

Hypertension is a key risk factor for cardiovascular disease. Currently, around a third of people with hypertension are undiagnosed, and of those diagnosed, around half are not taking antihypertensive medications. The World Health Organisation (WHO) estimates that high blood pressure directly or indirectly causes deaths of at least nine million people globally every year. PURPOSE OF REVIEW: In this review, we examine how emerging technologies might support improved detection and management of hypertension not only in the wider population but also within special population groups such as the elderly, pregnant women, and those with atrial fibrillation. RECENT FINDINGS: There is an emerging trend to empower patients to support hypertension screening and diagnosis, and several studies have shown the benefit of tele-monitoring, particularly when coupled with co-intervention, in improving the management of hypertension. Novel technology including smartphones and Bluetooth®-enabled tele-monitoring are evolving as key players in hypertension management and offer particular promise within pregnancy and developing countries. The most pressing need is for these new technologies to be properly assessed and clinically validated prior to widespread implementation in the general population.

Keywords: Apps; Hypertension; Self-management; Self-monitoring; Smartphones; Tele-monitoring.

Conflict of interest statement

Dr. Tucker reports grants from National Institute for Health Research (NIHR) (Applied Research Programme grant), the NIHR Collaboration for Leadership in Applied Health Research and Care Oxford at Oxford Health NHS Foundation Trust, Research Capacity funding and the National School for Primary Care Research, outside the submitted work. Dr. McManus reports grants from NIHR, during the conduct of the study, and grants from Omron, outside the submitted work. Drs. Kitt and Fox declare no conflict of interest relevant to this manuscript.

References

    1. Organisation WH. World Health Organization (2013), A global brief on hypertension. Report. 2013 April 2013. Contract No.: WHO/DCO/WHD/2013.2.
    1. Excellence NIFC. <NICE CG 107 hypertension-in-pregnancy-diagnosis-and-management-pdf-35109334011877.pdf>. 2011.
    1. England Public Health. Health matters: combating high blood pressure. : Public Health England, 2017. Accessed March 2019.
    1. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. doi: 10.1136/bmj.b1665.
    1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-Z.
    1. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada and the United States. Hypertension. 2004;43(1):10–17. doi: 10.1161/01.HYP.0000103630.72812.10.
    1. Fleming S, Atherton H, Mc Cartney D, Hodgkinson J, Greenfield S, Hobbs FD, et al. Self-screening and non-physician screening for hypertension in communities: a systematic review. Am J Hypertens. 2015;28(11):1316–1324. doi: 10.1093/ajh/hpv029.
    1. Authorities SH. Health survey for England—2011, health, social care and lifestyles. Health and Social Care Information Centre: SHA (now Publich Health England), 2011 (published Dec 2012) 20/12/2012. Report No.
    1. Wood S, Greenfield SM, Sayeed Haque M, Martin U, Gill PS, Mant J, et al. Influence of ethnicity on acceptability of method of blood pressure monitoring: a cross-sectional study in primary care. Br J Gen Pract. 2016;66(649):e577–e586. doi: 10.3399/bjgp16X685717.
    1. Hamilton W, Round A, Goodchild R, Baker C. Do community based self-reading sphygmomanometers improve detection of hypertension? A feasibility study. J Public Health Med. 2003;25(2):125–130. doi: 10.1093/pubmed/fdg027.
    1. Houle SK, Tsuyuki RT. Public-use blood pressure machines in pharmacies for identification of undetected hypertension in the community. J Clin Hypertens (Greenwich) 2013;15(4):302. doi: 10.1111/jch.12061.
    1. Nykamp D, Barnett CW. Use of stationary automated blood pressure devices in pharmacies. Am Pharm. 1992;32(6):33–36. doi: 10.1016/S0160-3450(15)31092-8.
    1. Alpert BS, Dart RA, Sica DA. Public-use blood pressure measurement: the kiosk quandary. J Am Soc Hypertens. 2014;8(10):739–742. doi: 10.1016/j.jash.2014.07.034.
    1. Tompson AC, Grant S, Greenfield SM, McManus RJ, Fleming S, Heneghan CJ, et al. Patient use of blood pressure self-screening facilities in general practice waiting rooms: a qualitative study in the UK. Br J Gen Pract. 2017;67(660):e467–ee73. doi: 10.3399/bjgp17X690881.
    1. Fletcher BR, Hinton L, Bray EP, Hayen A, Hobbs FR, Mant J, et al. Self-monitoring blood pressure in patients with hypertension: an internet-based survey of UK GPs. Br J Gen Pract. 2016;66(652):e831–e8e7. doi: 10.3399/bjgp16X687037.
    1. Tison GH, Singh AC, Ohashi DA, Hsieh JT, Ballinger BM, Olgin JE, Marcus GM and Pletcher MJ. Cardiovascular risk stratification using off-the-shelf wearables and a multi-task deep learning algorithm. Circulation. 2018;136(1:Supplement 1):A21042
    1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J. 2013;34(28):2159–2219. doi: 10.1093/eurheartj/eht151.
    1. Whelton PK, Carey RM, Aronow WS, Casey DE, Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138(17):e426–ee83.
    1. Hinderliter AL, Voora RA, Viera AJ. Implementing ABPM into clinical practice. Curr Hypertens Rep. 2018;20(1):5. doi: 10.1007/s11906-018-0805-y.
    1. Little P, Barnett J, Barnsley L, Marjoram J, Fitzgerald-Barron A, Mant D. Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care. BMJ. 2002;325(7358):258–259. doi: 10.1136/bmj.325.7358.258.
    1. Stojanova A, Koceski S, Koceska N. Continuous blood pressure monitoring as a basis for ambient assisted living (AAL)—review of methodologies and devices. J Med Syst. 2019;43(2):24. doi: 10.1007/s10916-018-1138-8.
    1. Nemati S, Lehman LW, Adams RP, Malhotra A. Discovering shared cardiovascular dynamics within a patient cohort. Conf Proc : Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference. 2012;2012:6526–6529.
    1. Zhang Q, Zhou D, Zeng X. Highly wearable cuff-less blood pressure and heart rate monitoring with single-arm electrocardiogram and photoplethysmogram signals. Biomed Eng Online. 2017;16(1):23. doi: 10.1186/s12938-017-0317-z.
    1. Kim J, Park J, Kim K, Chee Y, Lim Y, Park K. Development of a nonintrusive blood pressure estimation system for computer users. Telemed J E-Health : the official journal of the American Telemedicine Association. 2007;13(1):57–64. doi: 10.1089/tmj.2006.0034.
    1. Jamaladin H, van de Belt TH, Luijpers LC, de Graaff FR, Bredie SJ, Roeleveld N, et al. Mobile apps for blood pressure monitoring: systematic search in app stores and content analysis. JMIR Mhealth UHealth. 2018;6(11):e187. doi: 10.2196/mhealth.9888.
    1. Burke LE, Ma J, Azar KM, Bennett GG, Peterson ED, Zheng Y, et al. Current science on consumer use of Mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association. Circulation. 2015;132(12):1157–1213. doi: 10.1161/CIR.0000000000000232.
    1. Stergiou GS, Alpert B, Mieke S, Asmar R, Atkins N, Eckert S, et al. A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of medical instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) collaboration statement. Hypertension. 2018;71(3):368–374. doi: 10.1161/HYPERTENSIONAHA.117.10237.
    1. Plante TB, Urrea B, MacFarlane ZT, Blumenthal RS, Miller ER, 3rd, Appel LJ, et al. Validation of the instant blood pressure smartphone app. JAMA Intern Med. 2016;176(5):700–702. doi: 10.1001/jamainternmed.2016.0157.
    1. Plante TB, Appel LJ, Martin SS. Critical flaws in the validation of the instant blood pressure smartphone app-a letter from the app developers-reply. JAMA Intern Med. 2016;176(9):1410–1411. doi: 10.1001/jamainternmed.2016.4765.
    1. England NHS. Report of the Review of the Quality and Outcomes Framework in England. NHS England, 2018
    1. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004;291(11):1342–1349. doi: 10.1001/jama.291.11.1342.
    1. Grant RW, Pandiscio JC, Pajolek H, Woulfe A, Pelletier A, Kvedar J, Park ER. Implementation of a web-based tool for patient medication self-management: the Medication Self-titration Evaluation Programme (Med-STEP) for blood pressure control. Inform Primary Care. 2012;20(1):57–67. doi: 10.14236/jhi.v20i1.48.
    1. Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389. doi: 10.1371/journal.pmed.1002389.
    1. Cairns AE, Tucker KL, Leeson P, Mackillop LH, Santos M, Velardo C, et al. Self-management of postnatal hypertension: the SNAP-HT trial. Hypertension (Dallas, Tex 2018) 1979;72(2):425–432. doi: 10.1161/HYPERTENSIONAHA.118.10911.
    1. McManus Richard J, Mant Jonathan, Bray Emma P, Holder Roger, Jones Miren I, Greenfield Sheila, Kaambwa Billingsley, Banting Miriam, Bryan Stirling, Little Paul, Williams Bryan, Hobbs FD Richard. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. The Lancet. 2010;376(9736):163–172. doi: 10.1016/S0140-6736(10)60964-6.
    1. Mc Manus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808. doi: 10.1001/jama.2014.10057.
    1. Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17(4):535. doi: 10.1007/s11906-015-0535-3.
    1. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455–467. doi: 10.1097/HJH.0b013e32835ca8dd.
    1. McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–959. doi: 10.1016/S0140-6736(18)30309-X.
    1. Mc Lean G, Band R, Saunderson K, Hanlon P, Murray E, Little P, et al. Digital interventions to promote self-management in adults with hypertension systematic review and meta-analysis. J Hypertens. 2016;34(4):600–612. doi: 10.1097/HJH.0000000000000859.
    1. Band R, Bradbury K, Morton K, May C, Michie S, Mair FS, et al. Intervention planning for a digital intervention for self-management of hypertension: a theory-, evidence- and person-based approach. Implement Sci. 2017;12(1):25. doi: 10.1186/s13012-017-0553-4.
    1. Levine DM, Dixon RF, Linder JA. Association of structured virtual visits for hypertension follow-up in primary care with blood pressure control and use of clinical services. J Gen Intern Med. 2018;33(11):1862–1867. doi: 10.1007/s11606-018-4375-0.
    1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–2375. doi: 10.1001/jama.285.18.2370.
    1. Clark CE, McDonagh STJ, McManus RJ. Accuracy of automated blood pressure measurements in the presence of atrial fibrillation: systematic review and meta-analysis. J Hum Hypertens 2019 10.
    1. Sykes D, Dewar R, Mohanaruban K, Donovan K, Nicklason F, Thomas DM, et al. Measuring blood pressure in the elderly: does atrial fibrillation increase observer variability? BMJ. 1990;300(6718):162–163. doi: 10.1136/bmj.300.6718.162.
    1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074. doi: 10.1016/S0140-6736(06)68397-9.
    1. Why mothers die 2000-2002. National Institute for Clinical Excellence, Scottish Executive Health Department, Department of Health, Social Services and Public Safety . Northern Ireland the sixth report of the confidential enquiries into maternal deaths in the United Kingdom. London: RCOG Press; 2004.
    1. Health NCCfWsaCs. Hypertension in pregnancy: the management of hypertensive disorders during pregnancy. Published by the Royal College of Obstetricians and Gynaecologists. 2010.
    1. Tucker KL, Taylor KS, Crawford C, Hodgkinson JA, Bankhead C, Carver T, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017;17(1):442. doi: 10.1186/s12884-017-1605-0.
    1. Blumenthal S, Epps RP, Heavenrich R, Lauer RM, Lieberman E, Mirkin B, et al. Report of the task force on blood pressure control in children. Pediatrics. 1977;59(5 2 suppl:I-II):797–820.
    1. Nathan HL, de Greeff A, Hezelgrave NL, Chappell LC, Shennan AH. Accuracy validation of the microlife 3AS1-2 blood pressure device in a pregnant population with low blood pressure. Blood Press Monit. 2015;20(5):299–302. doi: 10.1097/MBP.0000000000000134.
    1. Nathan HL, de Greeff A, Hezelgrave NL, Chappell LC, Shennan AH. An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2. Blood Press Monit. 2015;20(1):52–55. doi: 10.1097/MBP.0000000000000086.
    1. Nathan HL, Duhig K, Vousden N, Lawley E, Seed PT, Sandall J, et al. Evaluation of a novel device for the management of high blood pressure and shock in pregnancy in low-resource settings: study protocol for a stepped-wedge cluster-randomised controlled trial (CRADLE-3 trial) Trials. 2018;19(1):206. doi: 10.1186/s13063-018-2581-z.
    1. Nathan HL, Seed PT, Hezelgrave NL, De Greeff A, Lawley E, Anthony J, et al. Early warning system hypertension thresholds to predict adverse outcomes in pre-eclampsia: a prospective cohort study. Pregnancy Hypertens. 2018;12:183–188. doi: 10.1016/j.preghy.2017.11.003.
    1. Webb AJ, Wilson M, Lovett N, Paul N, Fischer U, Rothwell PM. Response of day-to-day home blood pressure variability by antihypertensive drug class after transient ischemic attack or nondisabling stroke. Stroke. 2014;45(10):2967–2973. doi: 10.1161/STROKEAHA.114.005982.
    1. Webb AJS, Mazzucco S, Li L, Rothwell PM. Prognostic significance of blood pressure variability on beat-to-beat monitoring after transient ischemic attack and stroke. Stroke. 2018;49(1):62–67. doi: 10.1161/STROKEAHA.117.019107.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere